White label ELPA - ClinicalTrials.eu

Study Comparing Ribociclib and Palbociclib for Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
Study of Rituximab, Prednisolone and Betamethasone in Adult Patients with First Episode of Minimal Change Nephrotic Syndrome to Prevent Disease Relapse

Not recruiting

2 1 1 1
Investigated diseases:
- Nephrotic syndrome
Investigated drugs:
Study on Preventing Recurrent Pouchitis in Ulcerative Colitis Patients Using Fecal Microbiota Transplant and Sodium Chloride

Not recruiting

3 1 1 1
Investigated diseases:
- Enteritis
Investigated drugs:
- Allogeneic Faecal Microbiota
- Sodium Chloride
Study on Baricitinib for Treating New-Onset Juvenile Dermatomyositis in Children

Not recruiting

2 1 1 1
Investigated diseases:
- Dermatomyositis
Investigated drugs:
- Baricitinib
Study on the Safety and Effectiveness of MK-2870, Enfortumab Vedotin, and Pembrolizumab for Patients with Advanced Bladder Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Transitional cell carcinoma
Investigated drugs:
Study on ECUR-506A and ECUR-506D for Male Infants Under 9 Months with Neonatal Onset Ornithine Transcarbamylase Deficiency

Not recruiting

2 1 1
Investigated diseases:
- Ornithine transcarbamoylase deficiency
Investigated drugs:
- Adeno-Associated Virus Serotype Rh79 Containing The Human Otc Gene
Study Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression

Not recruiting

3 1 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
+6
Study on the Effectiveness and Safety of Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study of Emavusertib for Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Not recruiting

1 1 1
Investigated diseases:
- Acute myeloid leukaemia
- Myelodysplastic syndrome
Investigated drugs:
- Emavusertib
Study of RLY-4008 for Patients with Cholangiocarcinoma and Other Advanced Solid Tumors

Not recruiting

2 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
- Rly-4008

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies